Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study.
Balducci M, D'Agostino GR, Manfrida S, De Renzi F, Colicchio G, Apicella G, Mangiola A, Fiorentino A, Frascino V, Mantini G, De Bari B, Pompucci A, Valentini V, Anile C, Cellini N. Balducci M, et al. Among authors: mantini g. J Neurooncol. 2010 Mar;97(1):95-100. doi: 10.1007/s11060-009-9997-y. Epub 2009 Aug 25. J Neurooncol. 2010. PMID: 19705066 Clinical Trial.
External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study.
Mattiucci GC, Morganti AG, Valentini V, Ippolito E, Alfieri S, Antinori A, Crucitti A, D'Agostino GR, Di Lullo L, Luzi S, Mantini G, Smaniotto D, Doglietto GB, Cellini N. Mattiucci GC, et al. Among authors: mantini g. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):831-8. doi: 10.1016/j.ijrobp.2009.02.013. Epub 2009 May 8. Int J Radiat Oncol Biol Phys. 2010. PMID: 19427747 Clinical Trial.
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report.
Balducci M, Apicella G, Manfrida S, Mangiola A, Fiorentino A, Azario L, D'Agostino GR, Frascino V, Dinapoli N, Mantini G, Albanese A, de Bonis P, Chiesa S, Valentini V, Anile C, Cellini N. Balducci M, et al. Among authors: mantini g. Strahlenther Onkol. 2010 Oct;186(10):558-64. doi: 10.1007/s00066-010-2101-x. Epub 2010 Sep 30. Strahlenther Onkol. 2010. PMID: 20936460 Clinical Trial.
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis.
D'Agostino GR, Autorino R, Pompucci A, De Santis MC, Manfrida S, Di Lella G, Mantini G, Frascino V, Chiesa S, Albanese A, Dinapoli N, Azario L, Fiorentino A, Valentini V, Anile C, Balducci M. D'Agostino GR, et al. Among authors: mantini g. Strahlenther Onkol. 2011 Jul;187(7):421-5. doi: 10.1007/s00066-011-2228-4. Epub 2011 Jun 28. Strahlenther Onkol. 2011. PMID: 21713390
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.
Balducci M, Chiesa S, Diletto B, D'Agostino GR, Mangiola A, Manfrida S, Mantini G, Albanese A, Fiorentino A, Frascino V, De Bari B, Micciche' F, De Rose F, Morganti AG, Anile C, Valentini V. Balducci M, et al. Among authors: mantini g. Neuro Oncol. 2012 Jan;14(1):79-86. doi: 10.1093/neuonc/nor173. Epub 2011 Oct 12. Neuro Oncol. 2012. PMID: 21993440 Free PMC article.
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies.
Balducci M, Fiorentino A, De Bonis P, Chiesa S, Manfrida S, D'Agostino GR, Mantini G, Frascino V, Mattiucci GC, De Bari B, Mangiola A, Miccichè F, Gambacorta MA, Colicchio G, Morganti AG, Anile C, Valentini V. Balducci M, et al. Among authors: mantini g. Med Oncol. 2012 Dec;29(5):3478-83. doi: 10.1007/s12032-012-0263-3. Epub 2012 Jun 7. Med Oncol. 2012. PMID: 22674154 Clinical Trial.
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials.
Balducci M, Fiorentino A, De Bonis P, Chiesa S, Mangiola A, Mattiucci GC, D'Agostino GR, Frascino V, Mantini G, Alitto AR, Colosimo C, Anile C, Valentini V. Balducci M, et al. Among authors: mantini g. Strahlenther Onkol. 2013 Nov;189(11):926-31. doi: 10.1007/s00066-013-0410-6. Epub 2013 Aug 24. Strahlenther Onkol. 2013. PMID: 23974823 Clinical Trial.
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial.
Trodella L, Granone P, Valente S, Valentini V, Balducci M, Mantini G, Turriziani A, Margaritora S, Cesario A, Ramella S, Corbo GM, D'Angelillo RM, Fontana A, Galetta D, Cellini N. Trodella L, et al. Among authors: mantini g. Radiother Oncol. 2002 Jan;62(1):11-9. doi: 10.1016/s0167-8140(01)00478-9. Radiother Oncol. 2002. PMID: 11830308 Clinical Trial.
Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: a phase II study.
Gambacorta MA, Valentini V, Morganti AG, Mantini G, Miccichè F, Ratto C, Di Miceli D, Rotondi F, Alfieri S, Doglietto GB, Vargas JG, De Paoli A, Rossi C, Cellini N. Gambacorta MA, et al. Among authors: mantini g. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):130-8. doi: 10.1016/j.ijrobp.2004.02.003. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337548 Clinical Trial.
Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.
Gambacorta MA, Valentini V, Coco C, Morganti AG, Smaniotto D, Miccichè F, Mantini G, Barbaro B, Garcia-Vargas JE, Magistrelli P, Picciocchi A, Cellini N. Gambacorta MA, et al. Among authors: mantini g. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):139-48. doi: 10.1016/j.ijrobp.2004.01.051. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337549 Clinical Trial.
146 results